Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
Akabani G, Reardon DA, Coleman RE, Wong TZ, Metzler SD, Bowsher JE, Barboriak DP, Provenzale JM, Greer KL, DeLong D, Friedman HS, Friedman AH, Zhao XG, Pegram CN, McLendon RE, Bigner DD, Zalutsky MR.
Akabani G, et al. Among authors: coleman re.
J Nucl Med. 2005 Jun;46(6):1042-51.
J Nucl Med. 2005.
PMID: 15937318
Free article.
Clinical Trial.